Sources

7 Total Sources

Orforglipron Beats Semaglutide in 1,698-Adult Trial as Side Effects Hit 59%

Orforglipron Pill Outperforms Semaglutide for Weight Loss, Blood Sugar in Trial

ScienceDaily15h ago

Orforglipron Weight-Loss Pill Outperforms Oral Semaglutide in Phase 3 Trial

Number of Americans taking GLP-1s for weight loss hits record high: Survey - AOL

National Institutes of Health (NIH) (.gov)15h ago

Efficacy and safety of orforglipron, an oral small-molecule GLP-1 receptor agonist, on cardiometabolic outcomes: a meta-analysis and systematic review - PMC

Pharmacy Times15h ago

Oral Semaglutide Demonstrates Greater Weight Loss vs Orforglipron in Indirect Comparison | Pharmacy Times

nejm.org15h ago

Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist for Obesity Treatment | New England Journal of Medicine

AJMC.com Managed Markets Network15h ago

FDA Approves Oral Semaglutide as First GLP-1 Pill for Weight Loss | AJMC